For participants in clinical trials, the answer is a hard no. The Trump administration's decision to end funding for the U.S.

In today’s clinical trials, compared to those of the past, there is increasing complexity, greater data collection, and a ...

The role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial Supply Europe ...

There is insufficient evidence to support exclusive enteral nutrition as an adjunctive therapy for active ulcerative colitis, ...

A local breast cancer survivor is hoping to break down barriers when it comes to increasing diversity in medical trials.

Exploring Regulatory Affairs, the discipline dedicated to ensuring that new drugs and biologics are safe, effective, and ...

| Real-world evidence lets us see how HIV medicines work in real life, helping HCPs provide better care and improving ...

Dr. Kevin Kalinsky covers the gamut of the current treatment landscape for patients with HER2-negative breast cancer, ...

Clinical research is indeed a data beast. Healthcare organizations are practically drowning in patient information from their studies—everything from vitals to lab results to patient-reported outcomes ...

Thomas Moehring highlights how advanced technologies such as mass spectrometry, automation and AI are accelerating biomarker ...

Following peer review, applications are passed to the NIH’s funding institutes and centers, such as the National Institute of Allergy and Infectious Diseases (NIAID) or the National Cancer Institute ...